Pharmacology, Toxicology and Pharmaceutical Science
Disease
100%
Opiate
60%
Adverse Event
47%
Pharmacotherapy
46%
Drug-Drug Interaction
43%
Adverse Drug Reaction
40%
Pharmacokinetics
37%
Cohort Study
34%
Injury
34%
Infection
33%
Metered-Dose Inhaler
32%
Clinical Trial
32%
Medication Error
31%
Community Pharmacy
31%
Randomized Controlled Trial
31%
Pharmaceutical Care
28%
Pharmacoeconomics
25%
Antidepressant
23%
Prevalence
22%
Turmeric
20%
Electronic Prescribing
19%
Malignant Neoplasm
18%
Parkinson's Disease
18%
Toxic Injury
17%
Heart Failure
16%
Epileptic Absence
16%
Normal Human
15%
Comorbidity
15%
Drug Information
15%
Antiinfective Agent
15%
Asthma
15%
Drug Interaction
15%
Ketamine
15%
Intubation
15%
Bleeding
14%
Antibiotics
14%
Heart Infarction
14%
Prescription Drug
14%
Cross-Sectional Study
13%
High Performance Liquid Chromatography
13%
Warfarin
13%
Statin (Protein)
13%
Envenomation
13%
Chronic Disease
13%
Levodopa-Induced Dyskinesia
12%
Major Depression
12%
Elimination
12%
Antibiotic Agent
12%
Analgesic Agent
11%
Combination Therapy
11%
Osimertinib
11%
Placebo
11%
Monotherapy
11%
Bioavailability
11%
Infectious Agent
10%
Therapeutic Drug Monitoring
10%
Health Status
10%
Pandemic
10%
Non Small Cell Lung Cancer
10%
Side Effect
10%
Volume of Distribution
9%
Snakebite
9%
Observational Study
9%
Morphine
9%
Anticonvulsive Agent
9%
Salbutamol
9%
Stress Ulcer
9%
Septic Shock
9%
Microorganism
9%
Non-Steroidal Anti-Inflammatory Drug
8%
Vancomycin
8%
Symptom
8%
Dipeptidyl Carboxypeptidase Inhibitor
8%
Curcumin
8%
Tapentadol
8%
Creatinine
8%
Venous Thromboembolism
8%
Hydrogen Peroxide
8%
Poison Control Centers
8%
Anticoagulant Agent
7%
Antivenom
7%
Escitalopram
7%
Rheumatoid Arthritis
7%
Benzodiazepine
7%
Chemotherapy
7%
Neoplasm
7%
Crotalus
7%
Drug Utilization
7%
Doxorubicin
7%
Arthritis
7%
Retrospective Study
7%
Diabetes Mellitus
7%
Selective Serotonin Reuptake Inhibitor
7%
Pharmacogenomics
7%
Mouse
7%
Prothrombin Complex
7%
Cross Sectional Study
7%
Digoxin
7%
Drug Concentration
7%
Dietary Supplement
7%
Medicine and Dentistry
Drug Therapy
96%
Health Care Cost
70%
Emergency Department
44%
Opiate
41%
Systematic Review
39%
Telemedicine
35%
Telehealth
32%
Medicare
32%
Randomized Controlled Trial
32%
Malignant Neoplasm
31%
Clinician
28%
Telepathology
27%
Health Care
25%
Injury
25%
Diabetes
24%
Odds Ratio
24%
Epileptic Seizure
23%
Adverse Event
22%
Quality of Life
22%
Intubation
22%
Disease
21%
Health Status
20%
Cross Sectional Study
19%
Prevalence
18%
Diagnosis
18%
Pathologist
17%
Mental Health
17%
Breast Cancer
17%
Meta-Analysis
16%
Intensive Care Unit
16%
Cost-Effectiveness Analysis
15%
Apoplexy
15%
Neoplasm
15%
Anodyne
15%
Analgesia
15%
Logistic Regression Analysis
14%
Patient with Diabetes
14%
Drug Interaction
13%
Rapid Sequence Intubation
13%
Health Outcomes
12%
Ostomy
12%
Emergency Medicine
12%
Consultation
12%
Antibiotics
12%
Prescription Drug
11%
Intensive Care
11%
Patient Care
11%
Outpatient
11%
Electronic Health Record
11%
COVID-19
10%
Clinical Trial
10%
Bone Metastasis
10%
Observational Study
9%
Diagnostic Accuracy
9%
Hypercholesterolemia
9%
Pediatrics
9%
Antidepressant
9%
Sedative Agent
9%
Medicine
9%
Infection
9%
Medication Therapy Management Service
9%
Obesity
8%
Ambulatory Care
8%
ABC Transporter Subfamily B
8%
Cardiometabolic Risk
8%
Microbiome
8%
Patient-Reported Outcome
8%
Vagus Nerve Stimulation
8%
Myocardial Infarction
8%
Decision Making
8%
Veterans Affairs
8%
Cohort Analysis
8%
Diabetes Mellitus
8%
Disease Management
8%
Ischemia
7%
Primary Health Care
7%
Adverse Drug Reaction
7%
Venous Thromboembolism
7%
Microscopy
7%
Cancer Cell
7%
Nivolumab
7%
Intoxication
7%
Nodular Melanoma
7%
Arthritis
6%
Image Quality
6%
Teledermatology
6%
Propofol
6%
Teleradiology
6%
Soft Tissue Infection
6%
Immune Checkpoint Inhibitor
6%
Medication Compliance
6%
Network Meta-Analysis
6%
Anticonvulsant
6%
Estrogen Receptor Positive Breast Cancer
6%
Neuromuscular Blocking Agent
6%
Pharmaceutical Care
6%
Morphine
6%
Pain
6%
Hemoglobin A1c
6%
Symptom
6%
Keyphrases
United States
42%
United States Adults
33%
Confidence Interval
30%
Emergency Department
29%
Pharmacist
20%
Meta-analysis
18%
Critically Ill Patients
17%
Adjusted Odds Ratio
16%
Rapid Sequence Intubation
16%
Disposition Kinetics
16%
Systematic Meta-analysis
15%
Medical Expenditure Panel Survey
15%
Obese Patients
14%
Obesity
14%
Intensive Care Unit
13%
Healthcare Expenditure
12%
Antitumor Agents
12%
Drug Dosing
12%
Critically Ill
12%
Opioids
12%
Randomized Controlled Trial
12%
First-pass Success
12%
Pharmacy Students
12%
Arizona
11%
Epilepsy
11%
Pharmacy
11%
Self-reported Pain
10%
Odds Ratio
10%
Trauma Patients
10%
Metered Dose Inhaler
10%
Virtual Slide
10%
Albumin
10%
Hispanic
10%
Older Adults
9%
Pharmacokinetics
9%
Non-Hispanic
9%
College of Pharmacy
9%
Parkinson's Disease
9%
US Adults
8%
Cardiomyocytes
8%
Outcome-based Contracts
8%
All of Us Research Program
8%
Pharmacist Attitudes
8%
Comprehensive Medication Review
8%
Uvaria
8%
Pricing Method
8%
Virtual Pathology
8%
Student Pharmacists
8%
Asthma
8%
Levodopa-induced Dyskinesia
8%
Drug Interactions
8%
Adverse Effects
8%
Medicare Part D
8%
Health Outcomes
7%
Pharmacy School
7%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
7%
Breast Cancer
7%
Hydrogen Bonds (H-bonds)
7%
Adult Patients
7%
Prescription Drugs
7%
Diabetes
7%
Ketamine
7%
Etomidate
7%
PMDI
7%
Oxidative Stress
7%
L-DOPA
7%
Clinical Outcomes
7%
Health Status
7%
Pain Severity
7%
Acute Kidney Injury
7%
Medication Management
6%
Heart Failure
6%
Gene Expression
6%
Medicare Beneficiaries
6%
Group Contribution
6%
Scoping Review
6%
Type 2 Diabetes Mellitus (T2DM)
6%
Septic Shock
6%
Adverse Events
6%
High Dose
6%
Body Mass Index
6%
Pain Management
6%
Chronic Conditions
6%
Rocuronium
6%
Intubation Success
6%
Medication Errors
6%
Lymphocytic Leukemia
6%
Health Costs
6%
Jatropha
6%
123I-IMP
6%
Sodium Amobarbital
6%
Clinical Pharmacy
6%
Low-income Subsidy
6%
Phencyclidine
6%
Moclobemide
6%
Cimetidine
6%
Group Activity
6%
High Cost
6%
Medication Use
5%
Drug Expenditure
5%